Advaxis Stock Price

0.0597 (12.97%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Advaxis Inc ADXS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0597 12.97% 0.52 19:59:00
Close Price Low Price High Price Open Price Previous Close
0.5106 0.4435 0.539 0.46 0.4603
Bid Price Ask Price Spread News
0.52 0.5265 0.0065 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
17,109 15,194,073 $ 0.5042025 $ 7,660,890 1,517,952 0.2625 - 1.57
Last Trade Time Type Quantity Stock Price Currency
19:59:26 formt 2,000 $ 0.52 USD

Advaxis Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 34.97M 66.23M 66.16M $ 20.88M $ - 0.02 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Advaxis News

Date Time Source News Article
10/16/202017:05Edgar (US Regulatory)Current Report Filing (8-k)
10/08/202007:01Edgar (US Regulatory)Current Report Filing (8-k)
9/29/202009:09Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)
9/29/202008:59Edgar (US Regulatory)Current Report Filing (8-k)
9/10/202016:02Edgar (US Regulatory)Quarterly Report (10-q)
9/10/202016:01Edgar (US Regulatory)Current Report Filing (8-k)
8/03/202016:04Edgar (US Regulatory)Statement of Ownership (sc 13g)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ADXS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.40110.5390.390.44296581,895,1860.118929.64%
1 Month0.42080.5390.340.40457721,932,3790.099223.57%
3 Months0.600.61950.340.44856491,280,741-0.08-13.33%
6 Months0.650.880.340.56696481,262,805-0.13-20.0%
1 Year0.35351.570.26250.76367293,468,3340.166547.1%
3 Years3.8010.800.1810.89045512,122,539-3.28-86.32%
5 Years9.9716.2950.1812.471,590,704-9.45-94.78%

Advaxis Description

Advaxis Inc is a clinical stage biotechnology company operating in the United States. It focuses on discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology which utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate Specific Antigen (PSA) associated with prostate cancer.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201022 00:46:55